A new target for the treatment of liver cirrhosis has been identified.
A team from the Miguel Hernández University of Elche demonstrated that the protein LSECtin plays a key role in the new mechanism, Medical Express reports. LSECtin is typically expressed by specialized liver cells and blocks the proliferation of proinflammatory…